ask="N/A"
ask_size="N/A"
average_daily_volume="35687"
bid="3.950"
bid_size="2000"
book_value="0.000"
change="+0.085"
change_from_200_day_moving_average="-0.492"
change_from_50_day_moving_average="0.527"
change_from_52_week_high="-9.345"
change_From_52_week_low="1.305"
change_in_percent="+2.196%"
close="3.955"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.265"
ebitda="0.00"
eps_estimate_current_year="-5.060"
eps_estimate_next_quarter="-0.840"
eps_estimate_next_year="-3.180"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.990"
high_52_weeks="13.300"
last_trade_date="1/26/2017"
last_trade_price="3.955"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.810"
low_52_weeks="2.650"
market_capitalization="N/A"
moving_average_200_day="4.447"
moving_average_50_day="3.428"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.750"
open="3.820"
pe_ratio="N/A"
peg_ratio="-0.010"
percent_change_from_200_day_moving_average="-11.066%"
percent_change_from_50_day_moving_average="+15.388%"
percent_change_from_52_week_high="-70.263%"
percent_change_from_52_week_low="+49.245%"
previous_close="3.870"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.000"
stock_exchange="NCM"
symbol="CLBS"
volume="26957"
weeks_range_52="2.650 - 13.300"
